Non-alcoholic fatty liver disease (NAFLD) represents a heterogeneous and progressive condition with a major pathogenic interplay between both metabolic (e.g., obesity, insulin resistance) and genetic (e.g., PNPLA3 and TM6SF2) factors [1]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.